Apellis Pharmaceuticals, Inc.
NASDAQ:APLS
29.73 (USD) • At close January 16, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -528.628 | -652.172 | -746.354 | -344.874 | -304.707 | -127.502 | -51.006 | -27.125 | -46.516 | -10.788 | -3.962 |
| Depreciation & Amortization
| 1.704 | 1.487 | 1.492 | 0.637 | 0.24 | 0 | 0.012 | 0 | 0 | 0.007 | 0.006 |
| Deferred Income Tax
| 0 | 0 | 198.264 | 103.029 | 16.34 | 0 | 0.154 | 0 | 0 | 0 | -0.272 |
| Stock Based Compensation
| 105.945 | 91.085 | 70.667 | 45.376 | 21.144 | 7.733 | 5.419 | 1.079 | 0.546 | 0.659 | 0.272 |
| Change In Working Capital
| -200.169 | -15.698 | -93.522 | 19.586 | 53.15 | -12.04 | -1.187 | 0.043 | 0.628 | 0.175 | 0.239 |
| Accounts Receivables
| 0 | 2.375 | -10.103 | 0 | 0 | 0 | 0 | 0 | 0 | 0.045 | 0.04 |
| Inventory
| 0 | -69.397 | -16.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0.17 | 18.689 | 10.487 | -0.054 | -1.641 | 6.587 | 0.932 | 0.07 | 1.726 | 0.398 | 0.22 |
| Other Working Capital
| -200.339 | 32.635 | -77.589 | 19.64 | 54.79 | -18.628 | -2.119 | -0.027 | -1.098 | -0.223 | 0.019 |
| Other Non Cash Items
| 26.413 | 61.553 | 6.327 | 15.758 | 2.698 | 0.568 | 0.014 | 1.009 | 26.486 | 0.001 | 0.272 |
| Operating Cash Flow
| -594.735 | -513.745 | -563.126 | -160.488 | -211.135 | -131.241 | -46.595 | -26.003 | -18.856 | -9.947 | -3.445 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.773 | -1.524 | -1.103 | -5.422 | -1.693 | 0 | 0 | 0 | 0 | -0.02 | 0 |
| Acquisitions Net
| 0 | -61.417 | -248.719 | 311.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | -331.863 | -171.281 | -879.067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 393.28 | 420 | 567.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.099 | 61.417 | 248.719 | -311.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.674 | 59.893 | 247.616 | -316.989 | -1.693 | 0 | 0 | 0 | 0 | -0.02 | 0 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 322.874 | 184.211 | 0 | 26.365 | 0 | 0 | 0 | -0.275 |
| Common Stock Issued
| 384.387 | 380.12 | 380.363 | 381.423 | 109.581 | 131.194 | 150.063 | 14.863 | 0.002 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 10.112 | -14.461 | 11.873 | 369.304 | 204.33 | 0.709 | 20.947 | 14.863 | 41.235 | 18.831 | 7.436 |
| Financing Cash Flow
| 394.499 | 365.659 | 392.236 | 692.178 | 388.541 | 131.903 | 197.375 | 14.863 | 41.236 | 18.831 | 7.162 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.135 | -0.488 | -2.016 | 0.359 | 0.005 | -0.038 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -200.775 | -88.681 | 74.71 | 215.06 | 175.717 | 0.624 | 150.78 | -11.14 | 22.381 | 8.865 | 3.717 |
| Cash At End Of Period
| 352.299 | 553.074 | 641.755 | 567.045 | 351.985 | 176.268 | 175.644 | 24.863 | 36.004 | 13.623 | 4.758 |